Ruanne V Barnabas

Summary

Publications

  1. ncbi Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions
    Ruanne V Barnabas
    Department of Global Health, University of Washington, Seattle, WA 98104, USA
    Curr HIV Res 10:228-37. 2012
  2. ncbi The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis
    Ruanne V Barnabas
    Department of Global Health, University of Washington, Seattle, USA
    AIDS 25:1559-73. 2011
  3. ncbi Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study)
    Ruanne V Barnabas
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    J Acquir Immune Defic Syndr 57:238-44. 2011

Detail Information

Publications3

  1. ncbi Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions
    Ruanne V Barnabas
    Department of Global Health, University of Washington, Seattle, WA 98104, USA
    Curr HIV Res 10:228-37. 2012
    ..Mathematical models of HSV-2 and HIV-1 at a population level would be useful tools to estimate the potential impact and cost-effectiveness of higher dose HSV-2 suppressive therapy...
  2. ncbi The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis
    Ruanne V Barnabas
    Department of Global Health, University of Washington, Seattle, USA
    AIDS 25:1559-73. 2011
    ..We evaluated the association between malaria, herpes simplex virus type 2 (HSV-2) and tuberculosis (TB) coinfections and their treatment on HIV viral load...
  3. ncbi Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study)
    Ruanne V Barnabas
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    J Acquir Immune Defic Syndr 57:238-44. 2011
    ..To explore these relationships, we examined the impact of preexisting HSV-2 infection in an international HIV vaccine trial...